Different cutoff values of methacholine bronchial provocation test depending on age in children with asthma

Eun Lee1, Young-Ho Kim2, Seungbong Han3

  • 1Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea.

Insights

Establishing age-dependent cutoff values for bronchial hyperresponsiveness (BHR) using the methacholine challenge test (MCT) aids in diagnosing asthma in children. This study determined specific methacholine PC20 thresholds for children aged 6-15 years.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Diagnostic Medicine

Background:

  • Bronchial hyperresponsiveness (BHR) is a key feature of asthma.
  • Current diagnostic criteria for pediatric asthma lack age-specific BHR cutoffs.
  • This study addresses the need for age-dependent methacholine challenge test (MCT) values.

Purpose of the Study:

  • To establish age-specific cutoff values for methacholine PC20 in diagnosing asthma in children.
  • To investigate the relationship between age and BHR thresholds in pediatric asthma diagnosis.
  • To provide practical diagnostic guidelines for pediatric asthma.

Main Methods:

  • A cohort of 2383 children (6-15 years) including suspected asthmatics and healthy controls.
  • Methacholine challenge tests (MCTs) performed using the five-breath method.
  • Receiver-operator characteristic (ROC) curve analysis to determine optimal PC20 cutoff values for asthma diagnosis.

Main Results:

  • Methacholine PC20 cutoff values demonstrated a clear increasing trend with age.
  • Specific cutoff values ranged from 5.8 mg/mL at age 6 to 24.6 mg/mL at age 15.
  • These age-dependent values offer improved sensitivity and specificity for asthma diagnosis.

Conclusions:

  • Age-specific cutoff values for methacholine PC20 are crucial for accurate asthma diagnosis in children.
  • Implementing these age-dependent thresholds can refine the diagnostic process for pediatric asthma.
  • This approach offers a practical modification for diagnosing asthma in symptomatic children and adolescents.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K